In yet another volatile session on Thursday, stocks pared back gains despite a rebound in oil prices, after reports that a Gilead Sciences clinical trial for its remdesivir drug was not effective in treating coronavirus—though the company quickly disputed that it was an inconclusive trial.... [+]The Dow Jones Industrial Average was up 0.2%, just 40 points, on Thursday, while the S&P 500 and Nasdaq Composite both ended slightly negative.
Stocks rose earlier in the day, with the Dow up to 400 points higher, thanks to a rebound in oil prices: WTI crude oil futures have stabilized since their unprecedented drop earlier this week, rising over 40% in the last two days alone.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: